Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1095 | 2021 |
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 832 | 2022 |
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study VJ Hall, S Foulkes, A Saei, N Andrews, B Oguti, A Charlett, E Wellington, ... The Lancet 397 (10286), 1725-1735, 2021 | 788 | 2021 |
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, ... The Lancet 397 (10283), 1459-1469, 2021 | 689 | 2021 |
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 437 | 2021 |
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 360 | 2021 |
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant P Elliott, D Haw, H Wang, O Eales, CE Walters, KEC Ainslie, C Atchison, ... Science 374 (6574), eabl9551, 2021 | 123 | 2021 |
Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients EJ Carr, M Wu, R Harvey, EC Wall, G Kelly, S Hussain, M Howell, ... The Lancet 398 (10305), 1038-1041, 2021 | 93 | 2021 |
Predominance of enterovirus B and echovirus 30 as cause of viral meningitis in a UK population CW Holmes, SSF Koo, H Osman, S Wilson, J Xerry, CI Gallimore, DJ Allen, ... Journal of clinical virology 81, 90-93, 2016 | 71 | 2016 |
Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms RE Billany, H Selvaskandan, SF Adenwalla, KL Hull, DS March, ... Kidney international 99 (6), 1492-1494, 2021 | 67 | 2021 |
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells TI de Silva, G Liu, BB Lindsey, D Dong, SC Moore, NS Hsu, D Shah, ... Iscience 24 (11), 2021 | 63 | 2021 |
Exhaled SARS-CoV-2 quantified by face-mask sampling in hospitalised patients with COVID-19 CM Williams, D Pan, J Decker, A Wisniewska, E Fletcher, S Sze, S Assadi, ... Journal of Infection 82 (6), 253-259, 2021 | 45 | 2021 |
Detection of bacterioplankton using PCR probes as a diagnostic indicator for drowning; the Leicester experience GN Rutty, CJ Bradley, MJP Biggs, FE Hollingbury, SJ Hamilton, ... Legal Medicine 17 (5), 401-408, 2015 | 45 | 2015 |
The hrcA and hspR regulons of Campylobacter jejuni CW Holmes, CW Penn, PA Lund Microbiology 156 (1), 158-166, 2010 | 41 | 2010 |
Cluster of human parechovirus infections as the predominant cause of sepsis in neonates and infants, Leicester, United Kingdom, 8 May to 2 August 2016 JW Tang, CW Holmes, FA Elsanousi, A Patel, F Adam, R Speight, ... Eurosurveillance 21 (34), 30326, 2016 | 29 | 2016 |
Acute and chronic disease caused by enteroviruses JW Tang, CW Holmes Virulence 8 (7), 1062-1065, 2017 | 26 | 2017 |
Comparing hospitalised, community and staff COVID-19 infection rates during the early phase of the evolving COVID-19 epidemic JW Tang, S Young, S May, P Bird, J Bron, T Mohamedanif, C Bradley, ... The Journal of Infection 81 (4), 647, 2020 | 19 | 2020 |
Medicinally Relevant Modification of the Isoquinoline-1, 3-dione Scaffold via Metal-Free Arylation and Fluorination of Diazo Homophthalimides in Brønsted Acids A Golushko, D Dar’in, G Kantin, N Guranova, AV Vasilyev, M Krasavin Synthesis 51 (20), 3815-3824, 2019 | 10 | 2019 |
Outbreak of SARS-CoV-2 at a hospice: terminated after the implementation of enhanced aerosol infection control measures L Feathers, T Hinde, T Bale, J Hyde, PW Bird, CW Holmes, JW Tang Interface Focus 12 (2), 20210066, 2022 | 8 | 2022 |
A rapid RT-LAMP SARS-CoV-2 screening assay for collapsing asymptomatic COVID-19 transmission RC Allsopp, CM Cowley, RC Barber, C Jones, CW Holmes, PW Bird, ... Plos one 17 (9), e0273912, 2022 | 7 | 2022 |